Log in

Blueprint Medicines SEC Filings & 10K Form (NASDAQ:BPMC)

$67.63
-0.34 (-0.50 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$64.86
Now: $67.63
$68.15
50-Day Range
$61.50
MA: $70.83
$82.22
52-Week Range
$60.60
Now: $67.63
$102.98
Volume729,400 shs
Average Volume825,852 shs
Market Capitalization$3.65 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.65

SEC Filings

Blueprint Medicines (NASDAQ:BPMC) SEC Filings

DateFilerForm TypeView
02/18/2020
3:55 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2020
4:31 PM
Blueprint Medicines (Filer)
Form S-3ASR
02/13/2020
3:39 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2020
6:21 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
7:09 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2020
7:14 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
10:49 AM
Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/23/2020
3:29 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
3:24 PM
Blueprint Medicines (Filer)
Form 424B5
01/21/2020
3:44 PM
Blueprint Medicines (Filer)
Form 424B5
01/21/2020
3:09 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:48 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:47 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:10 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:04 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
7:13 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
4:32 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:46 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
3:38 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:33 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
6:31 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:32 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
4:07 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:16 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:16 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:39 AM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:16 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
3:32 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
7:20 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
3:33 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
5:51 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
12:03 PM
Blueprint Medicines (Filer)
Form CT ORDER
09/18/2019
3:24 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:35 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:18 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:18 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:17 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:35 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:34 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:20 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:31 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
5:23 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
6:53 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:26 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
3:45 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:15 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
6:23 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
7:08 PM
Blueprint Medicines (Issuer)
Rowland Charles A Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:42 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:39 PM
Blueprint Medicines (Issuer)
Rowland Charles A Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:38 PM
Blueprint Medicines (Issuer)
LYNCH DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:37 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:36 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:36 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:35 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:35 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:15 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
5:08 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:08 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:07 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:06 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
5:05 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:12 PM
Blueprint Medicines (Issuer)
Demetri George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:11 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
7:15 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
5:01 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:00 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:00 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
6:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
8:11 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:42 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:32 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
3:15 PM
Blueprint Medicines (Filer)
Form DEF 14A
03/29/2019
3:24 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
3:21 PM
Blueprint Medicines (Filer)
Form 424B5
03/27/2019
3:15 PM
Blueprint Medicines (Filer)
Form 424B5
03/27/2019
3:10 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2019
4:25 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
4:23 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
2:52 PM
Blueprint Medicines (Filer)
Form CT ORDER
03/15/2019
3:13 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2019
4:00 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:04 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:31 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:30 PM
Blueprint Medicines (Issuer)
Dorsch Marion (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:29 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:28 PM
Blueprint Medicines (Issuer)
Boral Anthony L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:25 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:25 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:24 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:24 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:45 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2019
3:35 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
6:31 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:51 PM
Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/13/2019
3:04 PM
Blueprint Medicines (Subject)
Third Rock Ventures II, L.P. (Filed by)
Form SC 13G/A
02/12/2019
8:42 AM
Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
11:07 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2019
3:15 PM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Correction

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel